论文部分内容阅读
目的:评估生长抑素(施他宁,STILAMIN)对急性水肿型胰腺炎(AEP)的治疗价值及应用指征.方法:用回顾性分析方法,将163例AEP按年龄及有否加用生长抑素分为4组.按下列指标评估:腹痛消失时间、血淀粉酶复常时间、转为急性重症胰腺炎(ANP)发生率、手术率、病死率.结果:大于55岁的两组,腹痛消失时间生长抑素治疗组(治疗组)为(2.5±1.7)天;无生长抑素组(对照组)为(4.9±2.2)天,P＜0.05;血淀粉酶复常时间治疗组为(3.2±1.8)天;对照组为(4.8±2.8)天,P＜0.05;转为ANP的发生率,治疗组为8％(3/40);对照组为23％(7/31),P＞0.05;转手术率,治疗组为5％(2/40);对照组为16％(5/31),P＞0.05.小于或等于55岁的两组,腹痛消失时间和血淀粉酶复常时间均无统计学差别.结论:AEP高龄患者早期应用生长抑素治疗,能缩短病程,改善预后.“,”Objective: To assess the value and indications of somatostatin(stilamin) in the treatment of acute edematous pancreatitis(AEP).Methods: Abdominal pain duration; raised serum amylase period; surgical intervention rate, mortality rate and occurrence rate of acute necrosis pancreatitis (ANP) were investigated in 163 cases with AEP. Results: In the old patients whose ages>55, abdominal pain duration was (2.5±1.7) days in treatment group with somatostatin and (4 9±2 2) days in control group respectively( P ...